Mechanisms of Resistance in Nontyphoidal Salmonella enterica Strains Exhibiting a Nonclassical Quinolone Resistance Phenotype

作者: Marianne Gunell , Mark A. Webber , Pirkko Kotilainen , Andrew J. Lilly , Jonathan M. Caddick

DOI: 10.1128/AAC.00121-09

关键词:

摘要: Nontyphoidal Salmonella enterica strains with a nonclassical quinolone resistance phenotype were isolated from patients returning Thailand or Malaysia to Finland. A total of 10 isolates seven serovars studied in detail, all which had reduced susceptibility (MIC ≥ 0.125 μg/ml) ciprofloxacin but either susceptible showed only low-level ≤ 32 nalidixic acid. Phenotypic characterization included testing by the agar dilution method and investigation efflux activity. Genotypic screening mutations resistance-determining regions (QRDR) gyrA, gyrB, parC, parE PCR denaturing high-pressure liquid chromatography amplification plasmid-mediated (PMQR) genes qnrA, qnrB, qnrS, qnrD, aac(6′)-Ib-cr, qepA PCR. PMQR was confirmed plasmid analysis, Southern hybridization, transfer. No QRDRs detected exception Thr57-Ser substitution within ParC seen S. serovar Typhimurium strains. The qnrA qnrS determinants detected. Plasmids carrying qnr alleles transferable vitro, reproducible Escherichia coli DH5α transformants. These data demonstrate emergence highly mobile genotype that, absence mutation topoisomerase genes, confers nontypical isolates. mechanism enables bacteria survive elevated concentrations, therefore, may be able expand during fluoroquinolone treatment. This is concern since mediated therefore mobilizable.

参考文章(34)
Pirkko Kotilainen, Susa Pitkänen, Anja Siitonen, Pentti Huovinen, Antti J Hakanen, In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility Annals of Clinical Microbiology and Antimicrobials. ,vol. 4, pp. 12- 12 ,(2005) , 10.1186/1476-0711-4-12
Ari Robicsek, Jacob Strahilevitz, George A Jacoby, Mark Macielag, Darren Abbanat, Chi Hye Park, Karen Bush, David C Hooper, Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Nature Medicine. ,vol. 12, pp. 83- 88 ,(2006) , 10.1038/NM1347
Francois-Xavier Weill, Sophie Bertrand, Francoise Guesnier, Sylvie Baucheron, Patrick A.D. Grimont, Axel Cloeckaert, Ciprofloxacin-resistant Salmonella Kentucky in travelers. Emerging Infectious Diseases. ,vol. 12, pp. 1611- 1612 ,(2006) , 10.3201/EID1210.060589
A. Robicsek, J. Strahilevitz, D. F. Sahm, G. A. Jacoby, D. C. Hooper, qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States Antimicrobial Agents and Chemotherapy. ,vol. 50, pp. 2872- 2874 ,(2006) , 10.1128/AAC.01647-05
Frank Møller Aarestrup, Kåre Mølbak, E. John Threlfall, Camilla Wiuff, Is It Time To Change Fluoroquinolone Breakpoints for Salmonella spp. Antimicrobial Agents and Chemotherapy. ,vol. 47, pp. 827- 829 ,(2003) , 10.1128/AAC.47.2.827-829.2003
Katie L. Hopkins, Martin Day, E. John Threlfall, Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Emerging Infectious Diseases. ,vol. 14, pp. 340- 342 ,(2008) , 10.3201/EID1402.070573
Sofia D. Nyberg, Monica Österblad, Antti J. Hakanen, Pentti Huovinen, Jari Jalava, THE FINNISH STUDY GROUP FOR ANTIMIC, Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scandinavian Journal of Infectious Diseases. ,vol. 39, pp. 417- 424 ,(2007) , 10.1080/00365540601105731
Antti Hakanen, Pirkko Kotilainen, Pentti Huovinen, Hans Helenius, Anja Siitonen, Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerging Infectious Diseases. ,vol. 7, pp. 996- 1003 ,(2001) , 10.3201/EID0706.010613